Kopf AW - Search Results

1

Occupation and the risk of malignant melanoma.

Pion IA, Rigel DS, Garfinkel L, Silverman MK, Kopf AW. Pion IA, et al. Among authors: kopf aw. Cancer. 1995 Jan 15;75(2 Suppl):637-44. doi: 10.1002/1097-0142(19950115)75:2+<637::aid-cncr2820751404>3.0.co;2-#. Cancer. 1995. PMID: 7804988

2

Influence of gender on survival in patients with stage I malignant melanoma.

Vossaert KA, Silverman MK, Kopf AW, Bart RS, Rigel DS, Friedman RJ, Levenstein M. Vossaert KA, et al. Among authors: kopf aw. J Am Acad Dermatol. 1992 Mar;26(3 Pt 2):429-40. doi: 10.1016/0190-9622(92)70068-q. J Am Acad Dermatol. 1992. PMID: 1564150 Free article. Review.

3

Level of education and the risk of malignant melanoma.

Lee PY, Silverman MK, Rigel DS, Vossaert KA, Kopf AW, Bart RS, Garfinkel L, Levenstein MJ. Lee PY, et al. Among authors: kopf aw. J Am Acad Dermatol. 1992 Jan;26(1):59-63. doi: 10.1016/0190-9622(92)70007-3. J Am Acad Dermatol. 1992. PMID: 1732337 Free article.

4

Factors influencing survival in melanoma.

Rigel DS, Friedman RJ, Kopf AW, Silverman MK. Rigel DS, et al. Among authors: kopf aw. Dermatol Clin. 1991 Oct;9(4):631-42. Dermatol Clin. 1991. PMID: 1934638 Review.

5

Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin.

Friedman RJ, Rigel DS, Silverman MK, Kopf AW, Vossaert KA. Friedman RJ, et al. Among authors: kopf aw. CA Cancer J Clin. 1991 Jul-Aug;41(4):201-26. doi: 10.3322/canjclin.41.4.201. CA Cancer J Clin. 1991. PMID: 2049635 Free article. Review.

6

Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi.

Rivers JK, Kopf AW, Vinokur AF, Rigel DS, Friedman RJ, Heilman ER, Levenstein M. Rivers JK, et al. Among authors: kopf aw. Cancer. 1990 Mar 1;65(5):1232-6. doi: 10.1002/1097-0142(19900301)65:5<1232::aid-cncr2820650533>3.0.co;2-8. Cancer. 1990. PMID: 2302671

7

Dysplastic nevi. Markers for increased risk for melanoma.

Rigel DS, Rivers JK, Kopf AW, Friedman RJ, Vinokur AF, Heilman ER, Levenstein M. Rigel DS, et al. Among authors: kopf aw. Cancer. 1989 Jan 15;63(2):386-9. doi: 10.1002/1097-0142(19890115)63:2<386::aid-cncr2820630231>3.0.co;2-6. Cancer. 1989. PMID: 2910446

8

Risk factors for the development of malignant melanoma--I: Review of case-control studies.

Evans RD, Kopf AW, Lew RA, Rigel DS, Bart RS, Friedman RJ, Rivers JK. Evans RD, et al. Among authors: kopf aw. J Dermatol Surg Oncol. 1988 Apr;14(4):393-408. doi: 10.1111/j.1524-4725.1988.tb03373.x. J Dermatol Surg Oncol. 1988. PMID: 3280634 Review.

9

The rate of malignant melanoma in the United States: are we making an impact?

Rigel DS, Kopf AW, Friedman RJ. Rigel DS, et al. Among authors: kopf aw. J Am Acad Dermatol. 1987 Dec;17(6):1050-3. doi: 10.1016/s0190-9622(87)80487-5. J Am Acad Dermatol. 1987. PMID: 3501436 No abstract available.

10

Risk of developing cutaneous malignant melanoma in atypical-mole syndrome: New York University experience and literature review.

Slade J, Salopek TG, Marghoob AA, Kopf AW, Rigel DS. Slade J, et al. Among authors: kopf aw. Recent Results Cancer Res. 1995;139:87-104. doi: 10.1007/978-3-642-78771-3_7. Recent Results Cancer Res. 1995. PMID: 7597314 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters